EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 27, 2025, before markets open. The company will host a conference call and webcast at 8:30 AM EDT on the same day.
The earnings discussion will be led by Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer). Interested parties can access the call through domestic (1-800-225-9448) or international (1-203-518-9708) dial-in numbers using the passcode EDAP.
EDAP TMS SA (Nasdaq: EDAP), leader globale nelle terapie robotiche basate sull'energia, ha programmato l'annuncio dei risultati finanziari del Quarto Trimestre e dell'Anno Completo 2024 per il 27 marzo 2025, prima dell'apertura dei mercati. L'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 AM EDT nello stesso giorno.
La discussione sui guadagni sarà guidata da Ryan Rhodes (CEO), Ken Mobeck (CFO) e François Dietsch (Chief Accounting Officer). Le parti interessate possono accedere alla chiamata attraverso i numeri di telefono nazionali (1-800-225-9448) o internazionali (1-203-518-9708) utilizzando il codice di accesso EDAP.
EDAP TMS SA (Nasdaq: EDAP), líder mundial en terapias robóticas basadas en energía, ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y del Año Completo 2024 para el 27 de marzo de 2025, antes de la apertura de los mercados. La empresa llevará a cabo una conferencia telefónica y una transmisión en vivo a las 8:30 AM EDT el mismo día.
La discusión sobre las ganancias será dirigida por Ryan Rhodes (CEO), Ken Mobeck (CFO) y François Dietsch (Chief Accounting Officer). Las partes interesadas pueden acceder a la llamada a través de números de marcación nacionales (1-800-225-9448) o internacionales (1-203-518-9708) utilizando el código de acceso EDAP.
EDAP TMS SA (Nasdaq: EDAP), 로봇 에너지 기반 치료의 글로벌 리더,는 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 27일 시장 개장 전으로 예정하였습니다. 회사는 같은 날 오전 8시 30분 EDT에 전화 회의 및 웹캐스트를 진행할 것입니다.
수익 논의는 Ryan Rhodes (CEO), Ken Mobeck (CFO) 및 François Dietsch (Chief Accounting Officer)가 이끌 것입니다. 관심 있는 분들은 국내 전화(1-800-225-9448) 또는 국제 전화(1-203-518-9708)를 통해 EDAP 비밀번호를 사용하여 전화를 접속할 수 있습니다.
EDAP TMS SA (Nasdaq: EDAP), leader mondial des thérapies robotiques basées sur l'énergie, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et l'année complète 2024 pour le 27 mars 2025, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique et un webinaire à 8h30 EDT le même jour.
La discussion sur les bénéfices sera animée par Ryan Rhodes (PDG), Ken Mobeck (CFO) et François Dietsch (Directeur de la comptabilité). Les parties intéressées peuvent accéder à l'appel via les numéros de téléphone nationaux (1-800-225-9448) ou internationaux (1-203-518-9708) en utilisant le code d'accès EDAP.
EDAP TMS SA (Nasdaq: EDAP), der weltweite Marktführer für robotergestützte, energiebasierte Therapien, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierth Quartal und das Gesamtjahr 2024 für den 27. März 2025 vor Markteröffnung angesetzt. Das Unternehmen wird am selben Tag um 8:30 Uhr EDT eine Telefonkonferenz und einen Webcast veranstalten.
Die Diskussion über die Einnahmen wird von Ryan Rhodes (CEO), Ken Mobeck (CFO) und François Dietsch (Chief Accounting Officer) geleitet. Interessierte Parteien können über die nationalen (1-800-225-9448) oder internationalen (1-203-518-9708) Einwahlnummern mit dem Zugangscode EDAP an der Konferenz teilnehmen.
- None.
- None.
Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT
AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27th, 2025.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Thursday, March 27th
Time: 8:30 am EDT
Domestic: 1-800-225-9448
International: 1-203-518-9708
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1706804&tp_key=5b71915afc
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP TMS introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ
When will EDAP release its Q4 and Full Year 2024 financial results?
What time is EDAP's Q4 2024 earnings conference call?
Who will be presenting at EDAP's Q4 2024 earnings call?